[1] Wichers M.J., van der Schouw Y.T., Moons K.G., Stam H.J., van Nieuwenhuizen O. Prevalence of cerebral palsy in The Netherlands (1977–1988). Eur. J. Epidemiol., 2001, 17, 527–532 http://dx.doi.org/10.1023/A:1014515520670CrossrefGoogle Scholar

[2] Himmelmann K., Hagberg G., Uvebrant P. The changing panorama of cerebral palsy in Sweden. X. Prevalence and origin in the birth-year period 1999–2002. Acta. Paediatr., 2008, 99, 1337–1343 http://dx.doi.org/10.1111/j.1651-2227.2010.01819.xGoogle Scholar

[3] Stanley F., Blair E., Alberman E. Cerebral palsies: epidemiology and causal pathways. Clinics in Developmental Medicine No. 151, Mac Keith Press, London, 2000 Google Scholar

[4] Cowan F., Rutherford M., Groenendaal F., Eken P., Mercuri E., Bydder G.M., et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet, 2003, 361, 736–742 http://dx.doi.org/10.1016/S0140-6736(03)12658-XCrossrefGoogle Scholar

[5] SCPE Collaborative Group. Prevalence and characteristics of children with cerebral palsy in Europe. Dev. Med. Child Neurol., 2002, 44, 633–640 Google Scholar

[6] Krageloh-Mann I., Cans C. Cerebral palsy update. Brain Dev., 2009, 31, 537–544 http://dx.doi.org/10.1016/j.braindev.2009.03.009CrossrefGoogle Scholar

[7] Ferrari F., Cioni G., Prechtl H.F. Qualitative changes of general movements in preterm infants with brain lesions. Early Hum. Dev., 1990, 23, 193–231 http://dx.doi.org/10.1016/0378-3782(90)90013-9CrossrefGoogle Scholar

[8] Hadders-Algra M. Putative neural substrate of normal and abnormal general movements. Neurosci. Biobehav. Rev., 2007, 31, 1181–1190 http://dx.doi.org/10.1016/j.neubiorev.2007.04.009CrossrefGoogle Scholar

[9] Benders M.J., Groenendaal F., Uiterwaal C.S., de Vries L.S. Perinatal arterial stroke in the preterm infant. Semin. Perinatol., 2008, 32, 344–349 http://dx.doi.org/10.1053/j.semperi.2008.07.003CrossrefGoogle Scholar

[10] Golomb M.R., Garg B.P., Saha C., Azzouz F., Williams L.S. Cerebral palsy after perinatal arterial ischemic stroke. J. Child Neurol., 2008, 23, 279–286 http://dx.doi.org/10.1177/0883073807309246CrossrefGoogle Scholar

[11] Russo R.N., Goodwin E.J., Miller M.D., Haan E.A., Connell T.M., Crotty M. Self-esteem, self-concept, and quality of life in children with hemiplegic cerebral palsy. J. Pediatr., 2008, 153, 473–477 http://dx.doi.org/10.1016/j.jpeds.2008.05.040CrossrefGoogle Scholar

[12] Van Zelst B.R., Miller M.D., Russo R.N., Murchland S., Crotty M. Activities of daily living in children with hemiplegic cerebral palsy: a cross-sectional evaluation using the Assessment of Motor and Process Skills. Dev. Med. Child Neurol., 2006, 48, 723–727 http://dx.doi.org/10.1017/S0012162206001551CrossrefGoogle Scholar

[13] Wichers M.J., Odding E., Stam H.J., van Nieuwenhuizen O. Clinical presentation, associated disorders and aetiological moments in Cerebral Palsy: a Dutch population-based study. Disabil. Rehabil., 2005, 27, 583–589 http://dx.doi.org/10.1080/09638280400018445CrossrefGoogle Scholar

[14] Hendricks H.T., Pasman J.W., van Limbeek J., Zwarts M.J. Motor evoked potentials in predicting recovery from upper extremity paralysis after acute stroke. Cerebrovasc. Dis., 2003, 16, 265–271 http://dx.doi.org/10.1159/000071126CrossrefGoogle Scholar

[15] Eyre J.A., Smith M., Dabydeen L., Clowry G.J., Petacchi E., Battini R. et al. Is hemiplegic cerebral palsy equivalent to amblyopia of the corticospinal system? Ann. Neurol., 2007, 62, 493–503 http://dx.doi.org/10.1002/ana.21108CrossrefGoogle Scholar

[16] Eyre J.A. Corticospinal tract development and its plasticity after perinatal injury. Neurosci. Biobehav. Rev., 2007, 31, 1136–1149 http://dx.doi.org/10.1016/j.neubiorev.2007.05.011CrossrefGoogle Scholar

[17] Clowry G.J. The dependence of spinal cord development on corticospinal input and its significance in understanding and treating spastic cerebral palsy. Neurosci. Biobehav. Rev., 2007, 31, 1114–1124 http://dx.doi.org/10.1016/j.neubiorev.2007.04.007CrossrefGoogle Scholar

[18] O’sullivan M.C., Miller S., Ramesh V., Conway E., Gilfillan K., McDonough S. et al. Abnormal development of biceps brachii phasic stretch reflex and persistence of short latency heteronymous reflexes from biceps to triceps brachii in spastic cerebral palsy. Brain, 1998, 121, 2381–2395 http://dx.doi.org/10.1093/brain/121.12.2381CrossrefGoogle Scholar

[19] Clowry G.J., Davies B.M., Upile N.S., Gibson C.L., Bradley P.M. Spinal cord plasticity in response to unilateral inhibition of the rat motor cortex during development: changes to gene expression, muscle afferents and the ipsilateral corticospinal projection. Eur. J. Neurosci., 2004, 20, 2555–2566 http://dx.doi.org/10.1111/j.1460-9568.2004.03713.xCrossrefGoogle Scholar

[20] Martin J.H., Friel K.M., Salimi I., Chakrabarty S. Activity- and usedependent plasticity of the developing corticospinal system. Neurosci. Biobehav. Rev., 2007, 31, 1125–1135 http://dx.doi.org/10.1016/j.neubiorev.2007.04.017CrossrefGoogle Scholar

[21] Chakrabarty S., Friel K.M., Martin J.H. Activity-dependent plasticity improves M1 motor representation and corticospinal tract connectivity. J. Neurophysiol., 2009, 101, 1283–1293 http://dx.doi.org/10.1152/jn.91026.2008Google Scholar

[22] Chakrabarty S., Martin J.H. Co-development of proprioceptive afferents and the corticospinal tract within the cervical spinal cord. Eur. J. Neurosci., 2011, 34, 682–694 http://dx.doi.org/10.1111/j.1460-9568.2011.07798.xCrossrefGoogle Scholar

[23] Judaš M., Radoš M., Jovanov-Milošević N., Hrabac P., Stern-Padovan R., Kostović I. Structural, immunocytochemical, and mr imaging properties of periventricular crossroads of growing cortical pathways in preterm infants. Am. J. Neuroradiol., 2005, 26, 2671–2684 Google Scholar

[24] Marin-Padilla M. Developmental neuropathology and impact of perinatal brain damage. II: white matter lesions of the neocortex. J. Neuropathol. Exp. Neurol., 1997, 56, 219–235 http://dx.doi.org/10.1097/00005072-199703000-00001CrossrefGoogle Scholar

[25] Inder T.E., Wells S.J., Mogridge N.B., Spencer C., Volpe J.J. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J. Pediatr., 2003, 143, 171–179 http://dx.doi.org/10.1067/S0022-3476(03)00357-3CrossrefGoogle Scholar

[26] Dubois J., Benders M., Cachia A., Lazeyras F., Ha-Vinh Leuchter R., Sizonenko S.V. et al. Mapping the early cortical folding process in the preterm newborn brain. Cereb. Cortex, 2008, 18, 1444–1454 http://dx.doi.org/10.1093/cercor/bhm180CrossrefGoogle Scholar

[27] Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol., 2009, 8, 110–124 http://dx.doi.org/10.1016/S1474-4422(08)70294-1CrossrefGoogle Scholar

[28] Murphy D.J., Sellers S., MacKenzie I.Z., Yudkin P.L., Johnson A.M. Casecontrol study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet, 1995, 346, 1449–1454 http://dx.doi.org/10.1016/S0140-6736(95)92471-XCrossrefGoogle Scholar

[29] Leviton A., Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci., 2007, 30, 473–478 http://dx.doi.org/10.1016/j.tins.2007.05.009CrossrefGoogle Scholar

[30] McQuillen P.S., Ferriero D.M. Selective vulnerability in the developing central nervous system. Pediatr. Neurol., 2004, 30, 227–235 http://dx.doi.org/10.1016/j.pediatrneurol.2003.10.001CrossrefGoogle Scholar

[31] Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci., 2001, 21, 1302–1312 Google Scholar

[32] Kinney H.C., Back S.A. Human oligodendroglial development: relationship to periventricular leukomalacia. Semin. Pediatr. Neurol., 1998, 5, 180–189 http://dx.doi.org/10.1016/S1071-9091(98)80033-8CrossrefGoogle Scholar

[33] Follett P.L., Rosenberg P.A., Volpe J.J., Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci., 2000, 20, 9235–9241 Google Scholar

[34] Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci., 2000, 20, 34–42 Google Scholar

[35] Back S.A., Han B.H., Luo N.L., Chricton C.A., Xanthoudakis S., Tam J. et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci., 2002, 22, 455–463 Google Scholar

[36] Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X. et al. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann. Neurol., 2008, 63, 520–530 http://dx.doi.org/10.1002/ana.21359CrossrefGoogle Scholar

[37] Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J. et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nature Med., 2005, 11, 966–972 Google Scholar

[38] Verney C., Monier A., Fallet-Bianco C., Gressens P. Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants. J. Anat., 2010, 217, 436–448 http://dx.doi.org/10.1111/j.1469-7580.2010.01245.xCrossrefGoogle Scholar

[39] Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A.M., Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology, 2001, 56, 1278–1284 CrossrefGoogle Scholar

[40] Haynes R.L., Folkerth R.D., Trachtenberg F.L., Volpe J.J., Kinney H.C. Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathol., 2009, 118, 391–399 http://dx.doi.org/10.1007/s00401-009-0540-1CrossrefGoogle Scholar

[41] Dommergues M.A., Plaisant F., Verney C., Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience, 2003, 121, 619–628 http://dx.doi.org/10.1016/S0306-4522(03)00558-XCrossrefGoogle Scholar

[42] Kostović I., Rakic P. Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J. Comp. Neurol., 1990, 297, 441–470 http://dx.doi.org/10.1002/cne.902970309CrossrefGoogle Scholar

[43] Ferriero D.M., Miller S.P. Imaging selective vulnerability in the developing nervous system. J. Anat., 2010, 217, 429–435 http://dx.doi.org/10.1111/j.1469-7580.2010.01226.xCrossrefGoogle Scholar

[44] Moore A.R., Filipovic R., Mo Z., Rasband M.N., Zecevic N., Antic S.D. Electrical excitability of early neurons in the human cerebral cortex during the second trimester of gestation. Cereb. Cortex, 2009, 19, 1795–1805 http://dx.doi.org/10.1093/cercor/bhn206CrossrefGoogle Scholar

[45] McQuillen P.S., Sheldon R.A., Shatz C.J., Ferriero D.M. Selective vulnerability of subplate neurons after early neonatal hypoxiaischemia. J. Neurosci., 2003, 23, 3308–3315 Google Scholar

[46] Nguyen V., McQuillen P.S. AMPA and metabotropic excitoxicity explain subplate neuron vulnerability. Neurobiol. Dis., 2010, 37, 195–207 http://dx.doi.org/10.1016/j.nbd.2009.10.002CrossrefGoogle Scholar

[47] Kanold P.O., Kara P., Reid R.C., Shatz C.J. Role of subplate neurons in functional maturation of visual cortical columns. Science 2003, 301, 521–525 http://dx.doi.org/10.1126/science.1084152CrossrefGoogle Scholar

[48] Luhmann H.J., Kilb W., Hanganu-Opatz I.L. Subplate cells: amplifiers of neuronal activity in the developing cerebral cortex. Front. Neuroanat., 2009, 3, 19 http://dx.doi.org/10.3389/neuro.05.019.2009CrossrefGoogle Scholar

[49] Kostović I., Judaš M. Prolonged coexistence of transient and permanent circuitry elements in the developing cerebral cortex of fetuses and preterm infants. Dev. Med. Child Neurol., 2006, 48, 388–393 http://dx.doi.org/10.1017/S0012162206000831CrossrefGoogle Scholar

[50] Eyre J.A., Miller S., Clowry G.J., Conway E.A., Watts C. Functional corticospinal projections are established prenatally in the human foetus permitting involvement in the development of spinal motor centres. Brain, 2000, 123, 51–64 http://dx.doi.org/10.1093/brain/123.1.51CrossrefGoogle Scholar

[51] Leijser L.M., de Bruine F.T., Steggerda S.J., van der Grond J., Walther F.J., van Wezel-Meijler G. Brain imaging findings in very preterm infants throughout the neonatal period: part I. Incidences and evolution of lesions, comparison between ultrasound and MRI. Early Hum. Dev., 2009, 85, 101–109 http://dx.doi.org/10.1016/j.earlhumdev.2008.11.010CrossrefGoogle Scholar

[52] Woodward L.J., Anderson P.J., Austin N.C., Howard K., Inder T.E. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. New Engl. J. Med., 2006, 355, 685–694 http://dx.doi.org/10.1056/NEJMoa053792CrossrefGoogle Scholar

[53] Evans N. Prognostic tests in babies: do they always help? Acta Paediatr., 2007, 96, 329–330 http://dx.doi.org/10.1111/j.1651-2227.2007.00126.xCrossrefGoogle Scholar

[54] Hoon A.H., Jr., Stashinko E.E., Nagae L.M., Lin D.D., Keller J., Bastian A. et al. Sensory and motor deficits in children with cerebral palsy born preterm correlate with diffusion tensor imaging abnormalities in thalamocortical pathways. Dev. Med. Child Neurol., 2009, 51, 697–704 http://dx.doi.org/10.1111/j.1469-8749.2009.03306.xCrossrefGoogle Scholar

[55] Lodygensky G.A., Vasung L., Sizonenko S.V., Hüppi P.S. Neuroimaging of cortical development and brain connectivity in human newborns and animal models. J. Anat., 2010, 217, 418–428 http://dx.doi.org/10.1111/j.1469-7580.2010.01280.xCrossrefGoogle Scholar

[56] Graziadio S., Basu A., Tomasevic L., Zappasodi F., Tecchio F., Eyre J.A. Developmental tuning and decay in senescence of oscillations linking the corticospinal system. J. Neurosci., 2010, 30, 3663–3674 http://dx.doi.org/10.1523/JNEUROSCI.5621-09.2010CrossrefGoogle Scholar

[57] Ende M., Ende N. Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va. Med. Mon. (1918), 1972, 99, 276–280 Google Scholar

[58] Haller M.J., Viener H.L., Wasserfall C., Brusko T., Atkinson M.A., Schatz D.A. Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematol., 2008, 36, 710–715 http://dx.doi.org/10.1016/j.exphem.2008.01.009CrossrefGoogle Scholar

[59] Haller M.J., Wasserfall C.H., McGrail K.M., Cintron M., Brusko T.M., Wingard J.R. et al. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care, 2009, 32, 2041–2046 http://dx.doi.org/10.2337/dc09-0967CrossrefGoogle Scholar

[60] Gao F., Wu D.Q., Hu Y.H., Jin G.X., Li G.D., Sun T.W. et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl. Res., 2008, 151, 293–302 http://dx.doi.org/10.1016/j.trsl.2008.03.003CrossrefGoogle Scholar

[61] Parekh V.S., Joglekar M.V., Hardikar A.A. Differentiation of human umbilical cord blood-derived mononuclear cells to endocrine pancreatic lineage. Differentiation, 2009, 78, 232–240 http://dx.doi.org/10.1016/j.diff.2009.07.004CrossrefGoogle Scholar

[62] Greco N., Laughlin M.J. Umbilical cord blood stem cells for myocardial repair and regeneration. Methods Mol. Biol., 2010, 660, 29–52 http://dx.doi.org/10.1007/978-1-60761-705-1_3CrossrefGoogle Scholar

[63] McGuckin C., Jurga M., Ali H., Strbad M., Forraz N. Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nature Protoc., 2008, 3, 1046–1055 http://dx.doi.org/10.1038/nprot.2008.69CrossrefGoogle Scholar

[64] Bone Marrow Donors Worldwide Annual Report, 2009, http://www.bmdw.org Google Scholar

[65] Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A. et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New Engl. J. Med., 2004, 351, 2276–2285 http://dx.doi.org/10.1056/NEJMoa041469CrossrefGoogle Scholar

[66] Stanevsky A., Goldstein G., Nagler A. Umbilical cord blood transplantation: pros, cons and beyond. Blood Rev., 2009, 23, 199–204 http://dx.doi.org/10.1016/j.blre.2009.02.001CrossrefGoogle Scholar

[67] Behzad-Behbahani A., Pouransari R., Tabei S.Z., Rahiminejad M.S., Robati M., Yaghobi R. et al. Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. Transplant Proc., 2005, 37, 3211–3212 http://dx.doi.org/10.1016/j.transproceed.2005.07.007CrossrefGoogle Scholar

[68] Pipes B.L., Tsang T., Peng S.X., Fiederlein R., Graham M., Harris D.T. Telomere length changes after umbilical cord blood transplant. Transfusion, 2006, 46, 1038–1043 http://dx.doi.org/10.1111/j.1537-2995.2006.00839.xCrossrefGoogle Scholar

[69] Slatter M.A., Gennery A.R. Umbilical cord stem cell transplantation for primary immunodeficiencies. Expert Opin. Biol. Ther., 2006, 6, 555–565 http://dx.doi.org/10.1517/14712598.6.6.555CrossrefGoogle Scholar

[70] Kang X.Q., Zang W.J., Bao L.J., Li D.L., Xu X.L., Yu X.J. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biol. Int., 2006, 30, 569–575 http://dx.doi.org/10.1016/j.cellbi.2006.02.007CrossrefGoogle Scholar

[71] McGuckin C.P., Forraz N., Baradez M.O., Navran S., Zhao J., Urban R. et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif., 2005, 38, 245–255 http://dx.doi.org/10.1111/j.1365-2184.2005.00346.xCrossrefGoogle Scholar

[72] McGuckin C., Forraz N., Baradez M.O., Basford C., Dickinson A.M., Navran S. et al. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. Acta Neurobiol. Exp., 2006, 66, 321–329 Google Scholar

[73] Harris D.T. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev., 2008, 4, 269–274 http://dx.doi.org/10.1007/s12015-008-9039-8CrossrefGoogle Scholar

[74] Arien-Zakay H., Lazarovici P., Nagler A. Tissue regeneration potential in human umbilical cord blood. Best Pract. Res. Clin. Haematol., 2010, 23, 291–303 http://dx.doi.org/10.1016/j.beha.2010.04.001CrossrefGoogle Scholar

[75] Forraz N., Pettengell R., McGuckin C.P. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells, 2004, 22, 100–108 http://dx.doi.org/10.1634/stemcells.22-1-100CrossrefGoogle Scholar

[76] Kucia M., Halasa M., Wysoczynski M., Baskiewicz-Masiuk M., Moldenhawer S., Zuba-Surma E. et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia, 2007, 21, 297–303 http://dx.doi.org/10.1038/sj.leu.2404470CrossrefGoogle Scholar

[77] Orkin S.H., Wang J., Kim J., Chu J., Rao S., Theunissen T.W. et al. The Transcriptional Network Controlling Pluripotency in ES Cells. Cold Spring Harb. Symp. Quant. Biol., 2008, 73, 195–202 http://dx.doi.org/10.1101/sqb.2008.72.001CrossrefGoogle Scholar

[78] Ma N., Stamm C., Kaminski A., Li W., Kleine H.D., Muller-Hilke B. et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res., 2005, 66, 45–54 http://dx.doi.org/10.1016/j.cardiores.2004.12.013CrossrefGoogle Scholar

[79] Denner L., Bodenburg Y., Zhao J.G., Howe M., Cappo J., Tilton R.G. et al. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif., 2007, 40, 367–380 http://dx.doi.org/10.1111/j.1365-2184.2007.00439.xCrossrefGoogle Scholar

[80] Werbowetski-Ogilvie T.E., Bosse M., Stewart M., Schnerch A., Ramos-Mejia V., Rouleau A. et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nature Biotechnol., 2009, 27, 91–97 http://dx.doi.org/10.1038/nbt.1516CrossrefGoogle Scholar

[81] Krtolica A. Stem cell: balancing aging and cancer. Int. J. Biochem. Cell Biol., 2005, 37, 935–941 http://dx.doi.org/10.1016/j.biocel.2004.10.007CrossrefGoogle Scholar

[82] Takenaka C., Nishishita N., Takada N., Jakt L.M., Kawamata S. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp. Hematol., 2010, 38, 154–162 http://dx.doi.org/10.1016/j.exphem.2009.11.003CrossrefGoogle Scholar

[83] Sommer C.A., Stadtfeld M., Murphy G.J., Hochedlinger K., Kotton D.N., Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 2009, 27, 543–549 http://dx.doi.org/10.1634/stemcells.2008-1075CrossrefGoogle Scholar

[84] Seo K.W., Lee S.R., Bhandari D.R., Roh K.H., Park S.B., So A.Y. et al. OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem. Biophys. Res. Commun., 2009, 384, 120–125 http://dx.doi.org/10.1016/j.bbrc.2009.04.094CrossrefGoogle Scholar

[85] Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M., Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood, 2000, 96, 2717–2722 Google Scholar

[86] Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E. et al. Hematopoietic engraftment and survival in adult recipients of umbilicalcord blood from unrelated donors. New Engl. J. Med., 2001, 344, 1815–1822 http://dx.doi.org/10.1056/NEJM200106143442402CrossrefGoogle Scholar

[87] Gluckman E., Rocha V., Boyer-Chammard A., Locatelli F., Arcese W., Pasquini R. et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. New Engl. J. Med., 1997, 337, 373–381 http://dx.doi.org/10.1056/NEJM199708073370602CrossrefGoogle Scholar

[88] Stevens C.E., Gladstone J., Taylor P.E., Scaradavou A., Migliaccio A.R., Visser J. et al. Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood, 2002, 100, 2662–2664 http://dx.doi.org/10.1182/blood.V100.7.2662CrossrefGoogle Scholar

[89] Brunstein C.G., Wagner J.E. Umbilical cord blood transplantation and banking. Ann. Rev. Med., 2006, 57, 403–417 http://dx.doi.org/10.1146/annurev.med.57.051804.123642CrossrefGoogle Scholar

[90] Zhang X., Hirai M., Cantero S., Ciubotariu R., Dobrila L., Hirsh A. et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J. Cell Biochem., 2011, 112, 1206–1218 http://dx.doi.org/10.1002/jcb.23042CrossrefGoogle Scholar

[91] Arien-Zakay H., Nagler A., Galski H., Lazarovici P. Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood. J. Mol. Neurosci., 2007, 32, 179–191 http://dx.doi.org/10.1007/s12031-007-0027-2CrossrefGoogle Scholar

[92] Arien-Zakay H., Lecht S., Bercu M.M., Amariglio N., Rechavi G., Galski H. et al. Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors. Leukemia, 2009, 23, 1790–1800 http://dx.doi.org/10.1038/leu.2009.106CrossrefGoogle Scholar

[93] Jang Y.K., Park J.J., Lee M.C., Yoon B.H., Yang Y.S., Yang S.E. et al. Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J. Neurosci. Res., 2004, 75, 573–584 http://dx.doi.org/10.1002/jnr.10789CrossrefGoogle Scholar

[94] Habich A., Jurga M., Markiewicz I., Lukomska B., Bany-Laszewicz U., Domanska-Janik K. Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Exp. Hematol., 2006, 34, 914–925 http://dx.doi.org/10.1016/j.exphem.2006.03.010CrossrefGoogle Scholar

[95] Jeong J.A., Gang E.J., Hong S.H., Hwang S.H., Kim S.W., Yang I.H. et al. Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport, 2004, 15, 1731–1734 http://dx.doi.org/10.1097/01.wnr.0000134846.79002.5cCrossrefGoogle Scholar

[96] Ha Y., Choi J.U., Yoon D.H., Yeon D.S., Lee J.J., Kim H.O. et al. Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport, 2001, 12, 3523–3527 http://dx.doi.org/10.1097/00001756-200111160-00030CrossrefGoogle Scholar

[97] McGuckin C.P., Forraz N., Allouard Q., Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res., 2004, 295, 350–359 http://dx.doi.org/10.1016/j.yexcr.2003.12.028CrossrefGoogle Scholar

[98] Chen N., Hudson J.E., Walczak P., Misiuta I., Garbuzova-Davis S., Jiang L. et al. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells, 2005, 23, 1560–1570 http://dx.doi.org/10.1634/stemcells.2004-0284CrossrefGoogle Scholar

[99] Sanberg P.R., Willing A.E., Garbuzova-Davis S., Saporta S., Liu G., Sanberg C.D. et al. Umbilical cord blood-derived stem cells and brain repair. Ann. N. Y. Acad. Sci., 2005, 1049, 67–83 http://dx.doi.org/10.1196/annals.1334.008CrossrefGoogle Scholar

[100] Sun W., Buzanska L., Domanska-Janik K., Salvi R.J., Stachowiak M.K. Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells, 2005, 23, 931–945 http://dx.doi.org/10.1634/stemcells.2004-0316CrossrefGoogle Scholar

[101] Jurga M., Lipkowski A.W., Lukomska B., Buzanska L., Kurzepa K., Sobanski T. et al. Generation of functional neural artificial tissue from human umbilical cord blood stem cells. Tissue Eng. Part C Methods, 2009, 15, 365–372 http://dx.doi.org/10.1089/ten.tec.2008.0485CrossrefGoogle Scholar

[102] Ali H., Forraz N., McGuckin C.P., Jurga M., Lindsay S., Ip B.K. et al. In vitro modelling of cortical neurogenesis by sequential induction of human umbilical cord blood stem cells. Stem Cell Rev. and Rep., (in press.) DOI 10.1007/s12015-011-9287-x CrossrefGoogle Scholar

[103] Ali H., Jurga M., Kurgonaite K., Forraz N., McGuckin C. Defined serumfree culturing conditions for neural tissue engineering of human cord blood stem cells. Acta Neurobiol. Exp., 2009, 69, 12–23 Google Scholar

[104] Wang T.T., Tio M., Lee W., Beerheide W., Udolph G. Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem. Biophys. Res. Commun., 2007, 357, 1021–1027 http://dx.doi.org/10.1016/j.bbrc.2007.04.046CrossrefGoogle Scholar

[105] Lim J.Y., Park S.I., Oh J.H., Kim S.M., Jeong C.H., Jun J.A. et al. Brainderived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Aktdependent signaling pathways. J. Neurosci. Res., 2008, 86, 2168–2178 http://dx.doi.org/10.1002/jnr.21669CrossrefGoogle Scholar

[106] Buzanska L., Machaj E.K., Zablocka B., Pojda Z., Domanska-Janik K. Human cord blood-derived cells attain neuronal and glial features in vitro. J. Cell Sci., 2002, 115, 2131–2138 Google Scholar

[107] Kohyama J., Abe H., Shimazaki T., Koizumi A., Nakashima K., Gojo S. et al. Brain from bone: efficient “meta-differentiation” of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation, 2001, 68, 235–244 http://dx.doi.org/10.1046/j.1432-0436.2001.680411.xCrossrefGoogle Scholar

[108] Zwart I., Hill A.J., Girdlestone J., Manca M.F., Navarrete R., Navarrete C. et al. Analysis of neural potential of human umbilical cord bloodderived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J. Neurosci. Res., 2008, 86, 1902–1915 http://dx.doi.org/10.1002/jnr.21649CrossrefGoogle Scholar

[109] Rooney G.E., Howard L., O’Brien T., Windebank A.J., Barry F.P. Elevation of cAMP in mesenchymal stem cells transiently upregulates neural markers rather than inducing neural differentiation. Stem Cells Dev., 2009, 18, 387–398 http://dx.doi.org/10.1089/scd.2008.0080CrossrefGoogle Scholar

[110] Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke, 2001, 32, 2682–2688 http://dx.doi.org/10.1161/hs1101.098367CrossrefGoogle Scholar

[111] Newcomb J.D., Ajmo C.T., Jr., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant., 2006, 15, 213–223 http://dx.doi.org/10.3727/000000006783982043CrossrefGoogle Scholar

[112] Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T. et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke, 2004, 35, 2390–2395 http://dx.doi.org/10.1161/01.STR.0000141681.06735.9bCrossrefGoogle Scholar

[113] Willing A.E., Lixian J., Milliken M., Poulos S., Zigova T., Song S. et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res., 2003, 73, 296–307 http://dx.doi.org/10.1002/jnr.10659CrossrefGoogle Scholar

[114] Ou Y., Yu S., Kaneko Y., Tajiri N., Bae E.C., Chheda S.H. et al. Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Res., 2010, 1366, 217–225 http://dx.doi.org/10.1016/j.brainres.2010.09.098CrossrefGoogle Scholar

[115] Chung D.J., Choi C.B., Lee S.H., Kang E.H., Lee J.H., Hwang S.H. et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci. Res., 2009, 87, 3554–3567 http://dx.doi.org/10.1002/jnr.22162CrossrefGoogle Scholar

[116] Zawadzka M., Lukasiuk K., Machaj E.K., Pojda Z., Kaminska B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol. Exp., 2009, 69, 46–51 Google Scholar

[117] Riegelsberger U.M., Deten A., Posel C., Zille M., Kranz A., Boltze J. et al. Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats. Exp. Neurol., 2011, 227, 218–223 http://dx.doi.org/10.1016/j.expneurol.2010.11.008CrossrefGoogle Scholar

[118] Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-Haerer A., Gantert M. et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr. Res., 2006, 59, 244–249 http://dx.doi.org/10.1203/01.pdr.0000197309.08852.f5CrossrefGoogle Scholar

[119] Pimentel-Coelho P.M., Magalhaes E.S., Lopes L.M., deAzevedo L.C., Santiago M.F., Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev., 2010, 19, 351–358 http://dx.doi.org/10.1089/scd.2009.0049CrossrefGoogle Scholar

[120] Xiao J., Nan Z., Motooka Y., Low W.C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev., 2005, 14, 722–733 http://dx.doi.org/10.1089/scd.2005.14.722CrossrefGoogle Scholar

[121] Lee J.A., Kim B.I., Jo C.H., Choi C.W., Kim E.K., Kim H.S. et al. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr. Res., 2010, 67, 42–46 http://dx.doi.org/10.1203/PDR.0b013e3181bf594bCrossrefGoogle Scholar

[122] Xia G., Hong X., Chen X., Lan F., Zhang G., Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J. Perinat. Med., 2010, 38, 215–221 http://dx.doi.org/10.1515/JPM.2010.021CrossrefGoogle Scholar

[123] Chen A., Siow B., Blamire A.M., Lako M., Clowry G.J. Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res., 2010, 5, 255–266 http://dx.doi.org/10.1016/j.scr.2010.08.004CrossrefGoogle Scholar

[124] Chen A., Dimambro N., Clowry G.J. A comparison of behavioural and histological outcomes of periventricular injection of ibotenic acid in neonatal rats at postnatal days 5 and 7. Brain Res., 2008, 1201, 187–195 http://dx.doi.org/10.1016/j.brainres.2008.01.066CrossrefGoogle Scholar

[125] Battistella V., de Freitas G.R., da Fonseca L.M., Mercante D., Gutfilen B., Goldenberg R.C. et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med., 2011, 6, 45–52 http://dx.doi.org/10.2217/rme.10.97CrossrefGoogle Scholar

[126] Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I. et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol., 2010, 67, 1187–1194 http://dx.doi.org/10.1001/archneurol.2010.248CrossrefGoogle Scholar

[127] Mazzini L., Ferrero I., Luparello V., Rustichelli D., Gunetti M., Mareschi K. et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol., 2010, 223, 229–237 http://dx.doi.org/10.1016/j.expneurol.2009.08.007CrossrefGoogle Scholar

[128] Saporta S., Kim J.J., Willing A.E., Fu E.S., Davis C.D., Sanberg P.R. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res., 2003, 12, 271–278 http://dx.doi.org/10.1089/152581603322023007CrossrefGoogle Scholar

[129] Nishio Y., Koda M., Kamada T., Someya Y., Yoshinaga K., Okada S. et al. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J. Neurosurg. Spine, 2006, 5, 424–433 http://dx.doi.org/10.3171/spi.2006.5.5.424CrossrefGoogle Scholar

[130] Kang K.S., Kim S.W., Oh Y.H., Yu J.W., Kim K.Y., Park H.K. et al. A 37-yearold spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy, 2005, 7, 368–373 http://dx.doi.org/10.1080/14653240500238160CrossrefGoogle Scholar

[131] Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol., 2002, 174, 11–20 http://dx.doi.org/10.1006/exnr.2001.7853CrossrefGoogle Scholar

[132] Yasuhara T., Hara K., Maki M., Mays R.W., Deans R.J., Hess D.C. et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J. Cereb. Blood Flow Metab., 2008, 28, 1804–1810 http://dx.doi.org/10.1038/jcbfm.2008.68CrossrefGoogle Scholar

[133] Pavlichenko N., Sokolova I., Vijde S., Shvedova E., Alexandrov G., Krouglyakov P. et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res., 2008, 1233, 203–213 http://dx.doi.org/10.1016/j.brainres.2008.06.123CrossrefGoogle Scholar

[134] Vendrame M., Gemma C., Pennypacker K.R., Bickford P.C., Davis Sanberg C., Sanberg P.R. et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol., 2006, 199, 191–200 http://dx.doi.org/10.1016/j.expneurol.2006.03.017CrossrefGoogle Scholar

[135] Ding D.C., Shyu W.C., Chiang M.F., Lin S.Z., Chang Y.C., Wang H.J. et al. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol. Dis., 2007, 27, 339–353 http://dx.doi.org/10.1016/j.nbd.2007.06.010CrossrefGoogle Scholar

[136] Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M. et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J. Cell Mol. Med., 2010, 14, 914–921 http://dx.doi.org/10.1111/j.1582-4934.2008.00671.xCrossrefGoogle Scholar

[137] Grigoriadis N., Lourbopoulos A., Lagoudaki R., Frischer J.M., Polyzoidou E., Touloumi O. et al. Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Exp. Neurol., 2011, 230, 78–89 http://dx.doi.org/10.1016/j.expneurol.2011.02.021CrossrefGoogle Scholar

[138] Maier I.C., Schwab M.E. Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Phil. Trans. R. Soc. Lond. B Biol. Sci., 2006, 361, 1611–1634 http://dx.doi.org/10.1098/rstb.2006.1890CrossrefGoogle Scholar

[139] Teng F.Y., Tang B.L. Axonal regeneration in adult CNS neurons—signaling molecules and pathways. J. Neurochem., 2006, 96, 1501–1508 http://dx.doi.org/10.1111/j.1471-4159.2006.03663.xCrossrefGoogle Scholar

[140] Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp. Neurol., 2008, 209, 294–301 http://dx.doi.org/10.1016/j.expneurol.2007.05.014CrossrefGoogle Scholar

[141] Altman J., Bayer S.A. Development of human spinal cord. Oxford University Press: New York, 2001 Google Scholar

[142] Hensch T.K. Critical period plasticity in local cortical circuits. Nature Rev. Neurosci., 2005, 6, 877–888 http://dx.doi.org/10.1038/nrn1787CrossrefGoogle Scholar

[143] Goldberg J.L., Klassen M.P., Hua Y., Barres B.A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science, 2002, 296, 1860–1864 http://dx.doi.org/10.1126/science.1068428CrossrefGoogle Scholar

[144] Chen J., Magavi S.S., Macklis J.D. Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 16357–16362 http://dx.doi.org/10.1073/pnas.0406795101CrossrefGoogle Scholar

[145] Ip B.K., Bayatti N., Howard N.J., Lindsay S., Clowry G.J. The corticofugal neuron-associated genes ROBO1, SRGAP1, and CTIP2 exhibit an anterior to posterior gradient of expression in early fetal human neocortex development. Cereb. Cortex, 2011, 21, 1395–1407 http://dx.doi.org/10.1093/cercor/bhq219Google Scholar

[146] Ip B.K., Wappler I., Peters H., Lindsay S., Clowry G.J., Bayatti N. Investigating gradients of gene expression involved in early human cortical development. J. Anat., 2010, 217, 300–311 http://dx.doi.org/10.1111/j.1469-7580.2010.01259.xCrossrefGoogle Scholar

[147] Mercuri E., Cowan F., Gupte G., Manning R., Laffan M., Rutherford M., et al. Prothrombic disorders and abnormal neurodeveopmental outcome in infants with neonatal cerebral infarction. Pediatrics, 2001, 107, 1400–1404. http://dx.doi.org/10.1542/peds.107.6.1400CrossrefGoogle Scholar